Online-Only Abstracts  by unknown
Online-Only Abstracts
Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus
aureus necrotizing pneumonia—results of a prospective observational study
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Abstract
Staphylococcal necrotizing pneumonia (NP) is a severe disease associated with Panton–Valentine leucocidin (PVL). NP was initially described
for methicillin-susceptible Staphylococcus aureus (MSSA) infection, but cases associated with methicillin-resistant S. aureus (MRSA) infection
have increased concomitantly with the incidence of community-acquired MRSA worldwide. The role of methicillin resistance in the severity
of NP remains controversial. The characteristics and outcomes of 133 patients with PVL-positive S. aureus community-acquired pneumonia
(CAP) were compared according to methicillin resistance. Data from patients hospitalized for PVL-positive S. aureus CAP in France from
1986 to 2010 were reported to the National Reference Centre for Staphylococci and were included in the study. The primary end point
was mortality. Multivariate logistic modelling and the Cox regression were used for subsequent analyses. We analysed 29 cases of PVL-
MRSA and 104 cases of PVL-MSSA pneumonia. Airway haemorrhages were more frequently associated with PVL-MSSA pneumonia.
However, no differences in the initial severity or the management were found between these two types of pneumonia. The rate of lethality
was 39% regardless of methicillin resistance. By Cox regression analysis, methicillin resistance was not found to be a signiﬁcant independent
predictor of mortality at 7 or 30 days (p 0.65 and p 0.71, respectively). Our study demonstrates that methicillin resistance is not associated
with the severity of staphylococcal necrotizing pneumonia.
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Abstract
Subtilase (SubAB) is a cytotoxin elaborated by some Shiga Toxin (Stx)-producing Escherichia coli (STEC) strains usually lacking the locus of
enterocyte effacement (LEE). Two variants of SubAB coding genes have been described: subAB1, located on the plasmid of the STEC O113
98NK2 strain, and subAB2, located on a pathogenicity island (PAI) together with the tia gene, encoding an invasion determinant described in
enterotoxigenic E. coli. In the present study, we determined the entire nucleotide sequence of the PAI containing the subAB2 operon,
termed Subtilase-Encoding PAI (SE-PAI), and identiﬁed its integration site in the pheV tRNA locus. In addition, a PCR strategy for
discriminating the two subAB allelic variants was developed and used to investigate their presence in E. coli strains belonging to different
pathotypes and in a large collection of LEE-negative STEC of human and ovine origin. The results conﬁrmed that subAB genes are carried
predominantly by STEC and showed their presence in 72% and 86% of the LEE-negative strains from human cases of diarrhoea and from
healthy sheep respectively. Most of the subAB-positive strains (98%) identiﬁed possessed the subAB2 allelic variant and were also positive for
tia, suggesting the presence of SE-PAI. Altogether, our observations indicate that subAB2 is the prevalent SubAB-coding operon in LEE-
negative STEC circulating in European countries, and that sheep may represent an important reservoir for human infections with these
strains. Further studies are needed to assess the role of tia and/or other genes carried by SE-PAI in the colonization of the host intestinal
mucosa.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 298–299
CMI Online-Only Abstracts 299
